Organisations Internationales et consortiums

In 2017, the MPP and the World Health Organization established the second three-year work plan as part of our official working relationship. The plan includes collaborating on a wide range of issues including: prioritising products for in-licensing quality assurance and patent transparency implementing the WHO treatment guidelines developing paediatric formulations (See Paediatric HIV Treatment Initiative (PHTI) in Consortia) preparing joint forecasts on the use of antiretroviral medicines in developing countries